4-Aminosalicylic Acid
Specifications
65-49-6CAS Number
200-613-5EC Number
4-amino-2-hydroxybenzoic acidIUPAC Name
C7H7NO3Chemical Formula
153.14 g/molMolecular Weight
4-Aminosalicylic acid; 4-Amino-2-hydroxybenzoic acid; 65-49-6; Aminosalicylic acid; P-AMINOSALICYLIC ACID; Paramycin; Parasal; Paser; Parasalindon; Deapasil; Apacil; Gabbropas; Parasalicil; Aminopar; Entepas; Pamacyl; Pasalon; Pasnodia; Pasolac; Propasa; Osacyl; Pasara; Pasem; Pasmed; Pasa; Para-Pas; Sanipirol-4; APAS; Benzoic acid, 4-amino-2-hydroxy-; PASK; Aminox; Pasdium; 2-Hydroxy-4-aminobenzoic acid; Hellipidyl; para-Amino salicylic acid; Pascorbic; PAS (acid); aminosalicylate; Aminosalyl; Helipidyl; Paser Granules; Salicylic acid, 4-amino-; 3-Hydroxy-4-carboxyaniline; Granupas; NIH 2939; NSC 2083; A 1909; Aminosalicylic Acid [USP]; NSC-2083; NSC2083; Aminosalicylic acid (USP); 5B2658E0N2; DTXSID2022591; CHEBI:27565; 4-14-00-01967 (Beilstein Handbook Reference); Acid, Aminosalicylic; p Aminosalicylic Acid; 4 Aminosalicylic Acid; para Aminosalicylic Acid; RefChem:912358; Alumino 4 Aminosalicylic Acid; DTXCID302591; p Aminosalicylic Acid Monolithium Salt; p Aminosalicylic Acid Monopotassium Salt; 200-613-5; Rezipas; Para-aminosalicylic acid; Pamisyl; Kyselina p-aminosalicylova; MFCD00007789; PAS; Amino-pas; Sanipriol-4; 4-Aminosalicylate; 4-Asa; 4-amino-2-hydroxy-benzoic acid; p-amino salicylic acid; MLS000069418; SMR000059110; MLS000069579; PAS (VAN); 4-Aminosalicylicacid; Benzoic acid, 4-aminohydroxy-; HSDB 3203; 4-amino salicylic acid; Kyselina p-aminosalicylova [Czech]; SR-01000002990; SMR000058830; EINECS 200-613-5; Mesalazine EP Impurity E; BRN 0473071; P.A.S; Aminosalicylic; AI3-50142; UNII-5B2658E0N2; ISONICOTINIC ACID HYDRAZIDE P-AMINOSALICYLATE SALT; Pamisyl (TN); Paser (TN); 4-Aminosalicyclic acid; Spectrum_000042; .gamma.-Aminosalicylate; Opera_ID_614; Spectrum2_000001; Spectrum3_000297; Spectrum4_000145; Spectrum5_000804; para-amino-salicyclic acid; WLN: ZR CQ DVQ; Salicyclic acid, 4-amino-; SCHEMBL2262; CHEMBL1169; BSPBio_001834; KBioGR_000590; KBioSS_000422; MLS001148121; 4-Aminosalicylic acid, 99%; BIDD:GT0175; DivK1c_000350; 4-amino-2-hydroxobenzoic acid; SPBio_000001; orb1224328; orb1309076; orb3026005; SCHEMBL4242531; p-Aminosalicylic acid STANDARD; SCHEMBL29450213; BDBM48319; GTPL13652; HMS501B12; HY-I0447R; KBio1_000350; KBio2_000422; KBio2_002990; KBio2_005558; KBio3_001334; 4-Aminobenzoic acid, 2-hydroxy-; 4-Aminosalicylic acid (Standard); 4-azanyl-2-oxidanyl-benzoic acid; cid_11988145; NINDS_000350; AMINOSALICYLIC ACID [HSDB]; HMS2090I07; HMS2093L14; HMS2236I04; HMS3371A17; HMS3715M08; HMS5084P13; KUC106682N; AMINOSALICYLIC ACID [VANDF]; P-AMINOSALICYLIC ACID [MI]; AMINOSALICYLIC ACID [MART.]; HY-I0447; AMINOSALICYLIC ACID [USP-RS]; AMINOSALICYLIC ACID [WHO-DD]; CCG-39969; EBC-03237; s5211; SBB056794; STL163955; AKOS000121200; CS-W023102; DB00233; FA10792; PB47849; 4-AMINO,2-HYDROXY-BENZOIC ACID; IDI1_000350; AMINOSALICYLIC ACID [ORANGE BOOK]; NCGC00018110-01; NCGC00018110-02; NCGC00018110-03; NCGC00018110-04; AC-12894; AS-11043; SY001079; AMINOSALICYLIC ACID [USP MONOGRAPH]; KSC-11-207-13; SBI-0051279.P003; SBI-0051279.P004; DB-054818; MESALAZINE IMPURITY E [EP IMPURITY]; A0420; A5033; NS00010608; ST50824394; EN300-18730; C02518; D00162; NEOPASALATE COMPONENT AMINOSALICYLIC ACID; P17508; AB00051913-20; F078671; Q229924; SR-01000002990-4; SR-01000002990-6; 4-Aminosalicylic acid, Vetec(TM) reagent grade, 99%; BRD-K80267133-001-17-7; BRD-K80267133-001-18-5; BRD-K80267133-001-19-3; Z90121065; 4-Amino-2-Hydroxybenzoic Acid; Mesalazine EP Impurity E; F2191-0245; para-aminosalicylic acid;Aminosalicylic acid;4-aminosalicylate; Aminosalicylic acid, United States Pharmacopeia (USP) Reference Standard; 4-Aminosalicylic acid, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11Synonyms